Private equity firm Ardian has taken a majority stake in Biofarma Group, an Italian manufacturer of neutraceuticals, from Milan-based sponsor White Bridge Investments.
Private equity firm Ardian has taken a majority stake in Biofarma Group, an Italian manufacturer of neutraceuticals, from Milan-based sponsor White Bridge Investments.